CPSC Proposes to Exempt Powder Forms of 2 Drugs from Child-Resistant Packaging
The Consumer Product Safety Commission has issued a proposed rule to amend its child-resistant packaging requirements to exempt powder formulations of two oral prescription drugs, colesevelam hydrochloride (for adults with type 2 diabetes mellitus) and sevelamer carbonate (for chronic kidney…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
disease patients on dialysis), on the basis that child-resistant packaging is not needed to protect young children from serious injury or illness. Comments are due by May 2, 2011.